Healthcare Analysts Tewari and Sevush discuss the announcement for lower GLP-1 pricing and the impact to Eli Lilly (LLY) on an Analyst/Industry conference call to be held on November 14 at 12 pm. Webcast Link
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LLY:
- Investors Flee Mangoceuticals Stock (MGRX) after Eli Lilly and Novo Nordisk Deny Partnership
- Pfizer Stock (PFE) Rises as Metsera Shareholders Approve $10B Acquisition
- Investors plan protest vote against Novo Nordisk board shakeup, Reuters reports
- Novo denies partnership with Mangoceuticals on obesity drug, Reuters says
- Eli Lilly says ‘no affiliation’ with Mangoceuticals